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Objective: Although normothermic cardiopulmonary bypass results in im-
proved cardiac outcome, patients do not benefit from hypothermia-medi-
ated brain protection and thus may be at high risk for ischemic brain
injury. The present study evaluated the efficacy of selective forced-air
cerebral cooling. Methods: Sixteen dogs were anesthetized with either
intravenous pentobarbital or inhaled halothane (n 5 8 for each group).
Temperatures were monitored in the esophagus (i.e., core), parietal epi-
dural space, and brain parenchyma. Normothermic atrial-femoral cardio-
pulmonary bypass and forced-air pericranial cooling (to approximately
13° C) were maintained for 150 minutes. Data between groups were
compared by means of repeated-measures analysis of variance and two-
sample t test. Within each group, brain-to-core temperature gradients were
compared to zero by means of the one-sample t test. Results: In pentobar-
bital-anesthetized dogs, after 30 minutes of cerebral cooling, temperatures
in the parietal epidural space and 1 cm and 2 cm beneath the dura were 3.3°
6 1.4° C (mean 6 standard deviation), 2.6° 6 1.3° C, and 1.1° 6 0.6° C
cooler than the core temperature, respectively. At the conclusion of the
study (i.e., 150 minutes), these temperatures were 4.5° 6 1.8° C, 3.9° 6
1.6° C, and 2.0° 6 0.9° C cooler than the core temperature, respectively.
Similar changes were observed in halothane-anesthetized dogs. Conclu-
sions: Regardless of the background anesthetic, the magnitude of selective
cerebral cooling observed in our study was larger than the 1° to 2° C
changes previously reported to modulate ischemic brain injury. (J Thorac
Cardiovasc Surg 1998;115:1350-7)
Improved surgical technique and myocardial pro-tection during cardiopulmonary bypass (CPB)
have significantly reduced perioperative cardiac
morbidity and mortality and overall morbidity and
mortality.1, 2 In an attempt to further improve car-
diac outcome, investigators have recently evaluated
“warm” or normothermic CPB (i.e., maintaining the
core temperature at or near 37° C).3-6 Using this
temperature management strategy, investigators
have demonstrated a significant improvement in
post-CPB cardiac outcome when compared with
traditional “cold” CPB.3, 6
Despite major advances in myocardial protection,
the number of deaths resulting from CPB-mediated
neurologic complications appears to be increas-
ing.l,7, 8 This is of particular concern in patients
undergoing normothermic CPB: that is, patients
subjected to normothermic CPB do not benefit from
cold-induced brain protection and thus potentially
remain at higher risk for CPB-related brain injury
resulting from focal ischemia (e.g., gaseous or par-
ticulate emboli washed into the cerebral circulation)
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and global ischemia (e.g., as accompanies severe
systemic hypotension or cardiac arrest).5
Alterations in temperature can affect the brain’s
ability to survive an ischemic insult.9-13 Specifically,
recent investigations have reported mild hypother-
mia (i.e., a mere 1° to 6° C decrease in temperature)
can significantly improve neurologic outcome after
focal or global brain ischemia.9, 13 The present study
evaluated the efficacy of selective forced-air cerebral
cooling in a canine model of normothermic CPB.
Materials and methods
All pilot and formal studies were approved by the
Institutional Animal Care and Use Committee.
Pilot studies. Before initiating our formal studies, the
principal investigator (C.T.W.) designed, in correspon-
dence with Augustine Medical, Inc. (Tom Anderson,
Eden Prairie, Minn.), and evaluated the cooling efficacy of
three convective helmet prototypes (i.e., soft fabric, air-
diffusing coverlets, or “blankets”). Six purpose-bred
hounds were studied. Background anesthetics consisted of
either high-dose pentobarbital [i.e., an anesthetic known
to decrease both cerebral blood flow [CBF] and metabolic
rate [CMR]) or halothane (i.e., a cerebral vasodilator
having little effect on CMR).
In an established canine model of normothermic CPB
and brain temperature monitoring,14, 15 maximal forced-
air pericranial cooling (i.e., cooling of the environment
immediately surrounding the calvarium) was initiated and
maintained for 150 minutes (Augustine Medical, Inc.,
Eden Prairie, Minn., Polar Air). At maximal cooling (i.e.,
1000 L/min flow at 10° C), temperature measured (with
the use of a flexible thermistor) at the cooling helmet was
approximately 13° C. The helmet prototype producing the
most efficient cooling profile was subsequently used to
conduct the formal studies.
Formal studies. Formal studies were conducted in 16
purpose-bred hounds. All dogs were fasted but had free
access to water for a minimum of 8 hours before the study
was begun. A forelimb vein was cannulated for fluid and
drug administration. After randomization, anesthesia was
induced with either pentobarbital 30 mg/kg intravenously
(n 5 8) or halothane 2% to 3% inspired in an induction
box (n 5 8). Once the dog was anesthetized, the trachea
was intubated and the lungs were mechanically ventilated
(Siemens-Elema AB, Solna, Sweden, model 900C). A
tidal volume of 15 to 20 ml/kg was used and the respira-
tory rate was adjusted to maintain arterial carbon dioxide
tension near 35 mm Hg. The inspired oxygen fraction was
adjusted to maintain arterial oxygen tension near 150 mm
Hg. Inspired and end-expired concentrations of oxygen,
carbon dioxide, nitrogen, and halothane were quantified
with the use of a Rascal II device (Albion Instruments,
Salt Lake City, Utah). Blood gases were measured by
means of the alpha-stat (temperature uncorrected) tech-
nique (Instrumentation Laboratory Company, Lexington,
Mass.; model BGE). Anesthesia was maintained during
the preparatory period with additional intravenous pen-
tobarbital or inspired halothane 1.0% to 1.5%. Neuro-
muscular block was induced and maintained with intrave-
nous pancuronium. The left femoral artery was
cannulated percutaneously with a 4.25-inch 18-gauge
catheter (Arrow International, Inc., Reading, Pa.) for
blood pressure measurements and blood sampling.
With the use of a sagittal incision, the scalp was
reflected laterally from the sagittal ridge. Bilateral parietal
burr holes, 1 cm in diameter, were created 1.5 cm lateral
to the midline and 3.0 cm rostral to the lambdoidal ridge.
Via these burr holes, epidural temperatures were mea-
sured by inserting catheter-style thermistors (Yellow
Springs Instrument Co., Inc., Yellow Springs, Ohio, model
555) 1.5 cm rostral to the anterior margin of each burr
hole. Additionally, with the use of the same burr holes,
intraparenchymal brain temperatures were measured with
needle thermistors (Yellow Springs Instrument Co., Inc.,
Yellow Springs, Ohio, model 552) inserted perpendicular
to the parietal cortex surface, to depths of 1 cm and 2 cm
beneath the dura bilaterally. During the pilot studies, we
observed that the distal tips of the 1 cm and 2 cm
intraparenchymal thermistors were located in subcortical
white matter and basal ganglia, respectively. After place-
ment of the intraparenchymal thermistors, the burr holes
were sealed with bone wax, and the portion of needle
thermistor protruding beyond the dura was thermally
insulated with foam tape (3M, St. Paul, Minn., Micro-
foam).
Electroencephalographic activity was recorded with the
use of gold cup electrodes (Grass Instrument Division,
Quincey, Mass., model E-6GH) glued to the calvarium. A
bifrontal and biparietal electroencephalogram was re-
corded with the use of a polygraph and a strip recorder
(Grass Instrument Division, Quincey, Mass., model 8-10).
So that insensible heat loss from the calvarium could be
minimized, the scalp was reapproximated toward midline,
without disrupting the trajectory of the intraparenchymal
needle thermistors. Any gaps in the suture line were
insulated with folded gauze sponges. Before each study,
all thermistors were calibrated manually with a mercury
thermometer used as a reference.
Core temperature was measured with a flexible vinyl
thermistor (Yellow Springs Instrument Co., Inc., Yellow
Springs, Ohio, model 401) placed in the esophagus to the
level of the right atrium. Thermistor position was con-
firmed by palpation at the time of thoracotomy.
Preparation for CPB was achieved by modifying previ-
ously described techniques.14 In brief, dogs were placed in
the right lateral decubitus position, and a left anterolat-
eral thoracotomy was performed in the fourth intercostal
space. Heparin (Elkins-Sinn, Cherry Hill, N.J.) 300 U/kg
was administered intravenously before cannulation. A
single-stage venous cannula (C. R. Bard, Inc., Murray
Hill, N.J., 34F) was inserted into the right atrial append-
age. Then, so that insensible heat loss from the thoracic
cavity could be minimized, the skin margins of the thora-
cotomy were reapproximated with multiple perforating
towel clips. Arterial cannulation was achieved by inserting
a 16F catheter (Sherwood–Davis & Geck, St. Louis, Mo.)
into the right common femoral artery. Femoral cannula-
tion was selected to prevent cerebral hyperperfusion
associated with inadvertent cannula tip malalignment. A
membrane oxygenator–heat exchanger (Medtronic, Inc.,
Minneapolis, Minn., Maxima), open venous reservoir,
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serial arterial filter (Pall Corporation, Fajardo, Puerto
Rico), and standard roller pump were used to provide
nonpulsatile perfusion. The pump prime consisted of an
electrolyte solution (Plasma-Lyte solution, 1000 ml, Bax-
ter Healthcare Corp., Deerfield, Ill.).
Once the preparatory period was complete, the anes-
thetic dose was adjusted to achieve a steady state. Specif-
ically, barbiturate-anesthetized dogs received incremental
pentobarbital in doses of 1 to 5 mg/kg intravenously to
achieve and maintain electroencephalographic burst sup-
pression; anesthesia in dogs receiving halothane was
maintained at 0.87% end-expired (1.0 minimum alveolar
concentration). Additionally, the cooling helmet was care-
fully placed around the head and neck to avoid movement
of the intracranial needle thermistors and accidental
hemorrhage in the heparinized dog. Before CPB, core and
cranial temperatures were maintained at 38.0° C by means
of convection-based surface warming techniques (Augus-
tine Medical, Inc., Eden Prairie, Minn., Bair Hugger).
Fine regional temperature control was attained with sup-
plemental heating lamps and pads. The ambient room
temperature was maintained near 22° C during the entire
study period. Before and during CPB, (1) the oxygen
fraction and total gas flows were adjusted to maintain the
arterial oxygen tension greater than 100 mm Hg and
arterial carbon dioxide tension near 35 mm Hg and (2)
sodium bicarbonate was given intravenously as needed to
maintain the base deficit at less than 2 mEq/L. Before
CPB, the systemic mean arterial blood pressure (MAP)
was allowed to spontaneously equilibrate in halothane-
anesthetized dogs. Although baseline values were rela-
tively large, no attempt was made to pharmacologically
decrease MAP because it remained within the range of
autoregulation.16 In contrast, pentobarbital-anesthetized
dogs received an intravenous infusion of phenylephrine
(i.e., a systemic vasoconstrictor that does not directly
affect cerebral vascular tone or CBF17) 80 mg/ml to
produce an MAP similar to that of the halothane group.
During CPB, the MAP was maintained near 75 mm Hg in
both groups by means of a phenylephrine infusion as
needed.
After a 20-minute stabilization period, normothermic
CPB (with flows of 100 ml/kg per minute) and maximal
forced-air pericranial cooling (i.e., approximately 13° C)
were initiated simultaneously and maintained for 150
minutes. Mechanical ventilation was terminated after the
onset of CPB. During CPB, anesthesia was maintained
with either (1) incremental doses of intravenous pento-
barbital in an amount sufficient to maintain electroen-
cephalographic burst suppression or (2) 1.0% halothane
added to the CPB circuit. Resulting brain temperatures
were recorded, and brain-to-core temperature gradients
were calculated by subtracting the core temperature from
regional brain temperature (derived by averaging right
and left values at each brain temperature monitoring site).
At the completion of the study, dogs were put to death
with high-dose pentobarbital (Fort Dodge Laboratories,
Fort Dodge, Iowa, Sleep Away) and discontinuation of
CPB.
Data analysis. Baseline physiologic variables were
compared between groups (halothane vs pentobarbital) by
means of the two-sample t test. Brain-to-core temperature
gradients were calculated by subtracting core from re-
gional brain temperature (derived by averaging right and
left values at each brain temperature monitoring site).
Within each group, brain-to-core temperature gradients
were compared to zero by means of the one-sample t test.
The 30-minute and 150-minute time periods were deter-
mined a priori to represent the approximate timing of
aortic cannulation and aortic crossclamp release, respec-
tively. Both time periods have been reported to be asso-
ciated with large embolic loads18, 19 and, thus, potential
brain ischemia. The effect of anesthetic agent (halothane
vs pentobarbital) was evaluated by means of a two-factor
repeated-measures analysis of variance model with brain-
to-core temperature gradient as the dependent variable,
anesthetic agent as an independent cross-classification
factor, and time as the repeated factor. Separate analyses
were performed for each temperature monitoring site.
Two-sample t tests, comparing temperature gradients for
halothane versus pentobarbital at 30 minutes and 150
minutes, were used to supplement these analyses.
Results
Groups were well matched for all systemic phys-
iologic variables at the start of (Table I) and
throughout the study period.
In pentobarbital-anesthetized dogs, all brain tem-
peratures began to decrease immediately after the
start of selective cerebral cooling (Fig. 1). This trend
continued throughout the 150-minute study period
(Fig. 1). At all times, forced-air cooling resulted in
brain-to-core temperature gradients of the superfi-
cial brain loci that were greater than gradients in
deeper brain loci. For example, after 30 minutes of
cerebral cooling, temperatures in the parietal epi-
dural space and 1 cm and 2 cm beneath the dura
were 3.3° 6 1.4° C (mean 6 standard deviation),
2.6° 6 1.3° C, and 1.1° 6 0.6° C cooler than the core
temperature, respectively (p , 0.001 for all intracra-
nial sites) (Table II). At the conclusion of the study
Table I. Control physiologic variables
Variable Halothane Pentobarbital
Weight (kg) 22.9 6 2.6 22.0 6 2.1
PaO2 (mm Hg) 151 6 9 151 6 9
PaCO2 (mm Hg) 36 6 1 35 6 2
pH 7.42 6 0.02 7.43 6 0.02
MAP (mm Hg) 107 6 16 95 6 9
Hemoglobin (gm/dl) 15.2 6 2.6 14.1 6 1.8
Temperature (°C)
Esophageal 38.0 6 0.1 38.0 6 0.1
Epidural 38.0 6 0.2 37.9 6 0.1
1 cm beneath dura 38.1 6 0.2 38.1 6 0.2
2 cm beneath dura 38.2 6 0.1 38.2 6 0.2
Values are mean 6 standard deviation (n 5 8 per group). There were no
significant differences between groups. PaO2 , Arterial oxygen tension;
PaCO2 , arterial carbon dioxide tension; MAP, mean arterial blood pres-
sure.
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(i.e., 150 minutes), these temperatures were 4.5° 6
1.8° C, 3.9° 6 1.6° C, and 2.0° 6 0.9° C cooler than
the core temperature, respectively (p , 0.001 for all
intracranial sites) (Table II).
Similar changes were observed in halothane-anes-
thetized dogs (Fig. 1). For example, after 30 minutes
of cooling, temperatures in the parietal epidural
space and 1 cm and 2 cm beneath the dura were 2.3°
6 0.6° C, 2.0° 6 0.8° C, and 0.7° 6 0.4° C cooler than
the core temperature, respectively (p , 0.001, p ,
0.001, and p 5 0.002, respectively) (Table II). After
150 minutes of cerebral cooling, these temperatures
were 3.8° 6 2.3° C, 3.4° 6 2.4° C, and 1.5° 6 1.7° C
cooler than the core temperature, respectively (p 5
0.002, p 5 0.005, and p 5 0.034, respectively).
From repeated-measures analysis of variance, the
brain-to-core temperature gradients in the parietal
epidural space and 1 cm and 2 cm beneath the dura
were significantly associated with time (p , 0.001 for
all three sites). Brain-to-core temperature gradients
were not significantly different between anesthetic
agents (p 5 0.23, p 5 0.48, and p 5 0.27 for epidural,
Fig. 1. Brain-to-core temperature gradients in pentobarbital- or halothane-anesthetized dogs undergoing
simultaneous normothermic CPB and forced-air cerebral cooling. Temperature of forced air was
approximately 13° C. Core temperature was assessed with the use of a flexible vinyl thermistor placed in the
esophagus to the level of the right atrium. Regional brain temperatures were measured with thermistors
placed bilaterally: (1) in the epidural space, (2) 1 cm beneath the dura, and (3) 2 cm beneath the dura.
Resulting brain-to-core temperature gradients were calculated by subtracting core from regional brain
temperature (derived by averaging right and left values at each brain temperature monitoring site). Thus
a negative value denotes that the cranial measurement site was cooler than the core temperature.
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1 cm, and 2 cm sites, respectively), and there was no
evidence of a significant time-by-agent interaction
(p 5 0.76, p 5 0.94, and p 5 0.84, respectively).
There were no significant differences in brain-to-
core temperature gradients between groups.
Discussion
The present study demonstrated that, regardless
of the background anesthetic, forced-air pericranial
cooling significantly decreased brain temperature,
independent of core temperature. Further, the mag-
nitude of selective brain cooling observed in our
study was larger than the 1° to 2° C change (see
below) previously reported to modulate ischemic
neurologic injury.
Brain injury after CPB. Patients undergoing
CPB-facilitated cardiac operations often have
postoperative alterations in neurologic and neu-
ropsychologic function.l,2, 5, 7, 8, 18, 19 For example,
Mills19 reported neuropsychologic deficits (i.e.,
cognitive changes) in 60% to 80% of patients 1
week after coronary artery bypass grafting
(CABG) and in 20% to 40% of patients 8 weeks
after CABG. He19 also identified major neuro-
logic deficits (i.e., fatal cerebral injury, stroke,
seizures) in up to 6% of patients after CPB.
Similarly, in a prospective multicenter study,
Roach and associates8 evaluated the effect of
elective CABG on neurologic outcome in 2108
patients. They reported that 6.1% of patients had
major neurologic deficits associated with a (1)
fivefold to tenfold increase in in-hospital mortal-
ity, (2) twofold to fourfold increase in average
length of postoperative hospital stay, and (3)
threefold to sixfold increase in discharge to a
skilled-nursing facility or rehabilitation center.8
Taken together, neurologic injury is probably the
most common source of morbidity and the second
most frequent cause of death after cardiac sur-
gery.l,7, 8, 19
Etiology of CPB-related brain injury. CPB-re-
lated brain injury is believed to be caused by show-
ers of air and particulate emboli washed into the
cerebral circulation (i.e., multifocal ischemia) and
low flow states (i.e., global ischemia accompanying
severe systemic hypotension or cardiac arrest).18, 19
Changes in temperature management during
CPB. Traditionally, hypothermic CPB has been
used to protect vital organs, including the brain,
from ischemic injury during cardiac surgery. In
contrast, a current trend is normothermic CPB.3-6
Studies evaluating the effect of this temperature
management strategy have reported significant im-
provements of cardiac outcome after cardiac oper-
ations.3, 6 However, lack of hypothermia-mediated
brain protection may predispose this patient popu-
lation to ischemic brain injury. For example, Martin
and associates5 compared patients undergoing
CABG with moderate hypothermia and those ex-
posed to normothermic CPB. They reported a
threefold increase in “total neurologic events” (in-
cluding stroke) in patients exposed to normothermic
CPB.
In response to this limitation (i.e., worsening of
neurologic outcome after normothermic CPB), we
evaluated a novel, noninvasive approach of provid-
ing brain protective therapy while permitting core
temperature to remain at normothermia. Selective,
rather than whole-body, cooling has the theoretic
advantage of providing brain protective therapy
Table II. Brain-to-core temperature gradients during normothermic CPB
Time
Pentobarbital (n 5 8) Halothane (n 5 8)
p† 95% CI‡Mean 6 SD p* Mean 6 SD p*
30 min
Epidural –3.3 6 1.4 ,0.001 22.3 6 0.6 ,0.001 0.09 22.1 to 10.2
1 cm 22.6 6 1.3 ,0.001 22.0 6 0.8 ,0.001 0.34 21.7 to 10.6
2 cm 21.1 6 0.6 ,0.001 20.7 6 0.4 0.002 0.11 21.0 to 10.1
150 min
Epidural 24.5 6 1.8 ,0.001 23.8 6 2.3 0.002 0.19 22.9 to 11.4
1 cm 23.9 6 1.6 ,0.001 23.4 6 2.4 0.005 0.64 22.7 to 11.7
2 cm 22.0 6 0.9 ,0.001 21.5 6 1.7 0.034 0.50 21.9 to 11.0
*One-sample t test comparing mean brain-to-core temperature gradient versus zero.
†Two-sample t test comparing mean brain-to-core temperature gradient for pentobarbital versus halothane.
‡Ninety-five percent confidence interval for the difference in mean brain-to-core temperature gradient between anesthetic agents (pentobarbital minus
halothane).
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while avoiding adverse changes in systemic physiol-
ogy (i.e., cardiac arrhythmias, myocardial ischemia,
decreased myocardial contractility, coagulopathy,
leftward shifting of the oxyhemoglobin dissociation
curve, and impaired function of the immune sys-
tem).20
Hypothermia-mediated brain protection. Re-
cently, numerous studies have demonstrated that
mild (i.e., 1° to 6° C) increases or decreases in
brain temperature during or immediately after
ischemia can significantly worsen or improve,
respectively, neurologic outcome after isch-
emia.11-13 The most dramatic examples of modu-
lation of ischemic brain injury by small alterations
in brain temperature have been reported by
Wass,11 Warner,12 and their colleagues. The
former investigators discovered that temperature
changes of either 1° or 2° C significantly altered
functional and histologic outcome in a canine
model of complete cerebral ischemia.11 The latter
authors discovered that a change in brain temper-
ature of 1.2° C significantly altered functional and
histologic outcome in a rat model of focal cerebral
ischemia.12 Consistent with the animal literature,
several groups of investigators have reported a
correlation between temperature and neurologic
outcome in human beings.9 For example, when
comparing patients experiencing an ischemic
stroke, Reith and colleagues9 demonstrated that
initial stroke severity, infarct size, functional out-
come, and mortality were significantly better in
individuals who were mildly hypothermic at the
time of hospital admission than in patients who
were normothermic. In contrast, fever signifi-
cantly worsened the neurologic outcome and the
mortality rate.9 Specifically, for each 1° C increase
in body temperature, the relative risk of a poor
neurologic outcome increased by a factor of 2.2.9
Mechanisms of brain protection by small changes
in temperature. The physiologic basis by which
small temperature changes produce significant alter-
ations in postischemic neurologic outcome has not
been fully elucidated. Proposed mechanisms include
alterations in (1) CMR, (2) membrane stability
(including the blood-brain barrier), (3) membrane
depolarization, (4) temperature-induced ion ho-
meostasis (including calcium fluxes), (5) neurotrans-
mitter release or reuptake (e.g., glutamate or aspar-
tate), (6) enzyme function (e.g., phospholipase,
xanthine oxidase, or nitric oxide synthase activity),
and (7) free radical production or endogenous scav-
enging.13
Determinants of brain temperature. It has been
theorized that brain temperature results from three
major factors: CBF (i.e., heat flux between the brain
and core), CMR (i.e., endogenous heat production),
and heat exchange with the environment.13, 21 The
significance of each “compartment” has previously
been reviewed.13
In our study, we pharmacologically altered two of
the temperature “compartments” (i.e., CBF and
CMR). In the setting of normothermic CPB, we did
not observe anesthetics possessing differing effects
on CBF and CMR to have a significant effect on
brain temperature. This probably indicates that the
efficacy of forced-air pericranial cooling was suffi-
cient to overwhelm any differences in brain temper-
ature that may have resulted from the differing
pharmacologic profiles of the two anesthetics. We
also noted that brain temperature decreased, begin-
ning with the outermost brain layers. This phenom-
enon has been clearly documented in subjects hav-
ing either nonischemic21, 22 or ischemic23 brains.
Limitations. We did not quantify changes in
brain temperature associated with pharmacologic
alteration in CBF or CMR. This may be viewed as a
potential study design limitation. However, it was
not our intent to quantify changes of brain temper-
ature associated with alterations in each “compart-
ment.” Rather, we simply observed the overall effect
of forced-air cooling on brain temperature in dogs
anesthetized with two anesthetics having divergent
effects on cerebral physiology. Within each group,
we observed significant decreases in brain-to-core
temperature gradients, indicating that selective
forced-air cooling was effective in each group. We
did not detect a significant difference in brain-to-
core temperature gradients between groups. How-
ever, with only eight animals in each group, we
cannot make definitive conclusions with respect to
differences between anesthetic agents.
In interpreting our results, one should consider
several anatomic and physiologic features of the dog
model. In our study, the dog model was chosen
because its mass and thickness of cranial fat approx-
imated the human condition as well as any nonpri-
mate species. However, the temporalis muscles in
the dog are thick, and the calvarium deviates from a
spherical shape, thus biasing our study toward a
negative result. Potentially offsetting these factors
are the facts that the dog brain is smaller than the
human brain. Additionally, dogs share with cats, but
not human beings, a vascular mechanism that, dur-
ing panting (i.e., spontaneous ventilation), protects
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the brain against overheating during hyperther-
mia.24 Specifically, evaporative heat loss associated
with air exchange in the mouth, nose, and upper
airways results in cooling of an intracranial arterio-
venous countercurrent heat exchanger known as the
rete mirabile.24 The rete mirabile is a vascular
network formed by division of the carotid artery into
a fine network of arterioles surrounded by the
cavernous sinus. In studies evaluating changes in
brain temperature in spontaneously ventilating dogs
(without tracheal intubation), this may threaten the
validity of the resulting data. However, in our stud-
ies, mechanical ventilation was terminated at the
onset of the study period (i.e., during normothermic
CPB). Thus, evaporative heat loss from respiratory
mucosa would be negligible, rendering the rete
relatively inactive. As evidence for this, the rete
(which is small in the dog) is designed to cool the
deep brain structure in preference to the superficial
brain structures. In our studies, the superficial brain
structures were cooler than the deep structures,
reflecting that forced-air surface cooling, not the
rete mirabile, was predominant in inducing brain-
to-core temperature gradients.
Summary
The magnitude of selective brain cooling ob-
served in our study was larger than the 1° to 2° C
changes previously reported to modulate ischemic
injury. Additionally, the effectiveness of selective
cerebral forced-air cooling was observed in both
treatment groups and was not associated with dif-
ferences in brain temperatures resulting from the
different pharmacologic profiles of halothane versus
pentobarbital. When these observations are extrap-
olated to human beings undergoing normothermic
CPB, we speculate that selective convective brain
cooling may enable clinicians to simultaneously im-
prove both cardiac (i.e., resulting from normother-
mic CPB) and neurologic (i.e., resulting from non-
invasive hypothermia-mediated brain protection)
outcomes after cardiac operations. In addition to its
potential applicability in patients undergoing car-
diac operations, we speculate that selective forced-
air cerebral cooling may be of benefit in other
groups of patients, including those having a stroke
or undergoing extracranial cerebrovascular surgery
(e.g., carotid endarterectomy).
We thank William Anding, Richard Koenig, Marilyn
Oeltjen, and Rebecca Wilson for their technical assistance
in the Cardiovascular Surgery and Neuroanesthesia Re-
search Laboratories.
R E F E R E N C E S
1. Cosgrove DM, Loop FD, Lytle BW, Baillot R, Gill CC,
Golding LA, et al. Primary myocardial revascularization:
trends in surgical mortality. J Thorac Cardiovasc Surg 1984;
88:673-84.
2. Stump DA, Rogers AT, Hammon JW, Newman SP. Cerebral
emboli and cognitive outcome after cardiac surgery. J Car-
diothorac Vasc Anesth 1996;10:113-9.
3. Kavanagh BP, Mazer CD, Panos A, Lichtenstein SV. Effect
of warm heart surgery on perioperative management of
patients undergoing urgent cardiac surgery. J Cardiothorac
Vasc Anesth 1992;6:127-31.
4. Singh AK, Feng WC, Bert AA, Rotenberg FA. Warm body,
cold heart: myocardial revascularization in 2383 consecutive
patients. J Cardiovasc Surg 1993;34:415-21.
5. Martin TD, Craver JM, Gott JP, Weintraub WS, Ramsey J,
Mora CT, et al. Prospective, randomized trial of retrograde
warm blood cardioplegia: myocardial benefit and neurologic
threat. Ann Thorac Surg 1994;57:298-304.
6. Lichtenstein SV, Ashe KA, El Dalati H, Cusimano RJ, Panos
A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc
Surg 1991;101:269-74.
7. Gardner TJ, Horneffer PJ, Manolio TA, Pearson TA, Gott
VL, Baumgartner WA, et al. Stroke following coronary artery
bypass grafting: a ten-year study. Ann Thorac Surg 1985;40:
574-81.
8. Roach GW, Kanchuger M, Mora-Mangano C, Newman M,
Nussmeier N, Wolman R, et al. Adverse cerebral outcomes
after coronary bypass surgery. N Engl J Med 1996;335:1857-
63.
9. Reith J, Jørgensen HS, Pedersen PM, Nakayama H, Ra-
aschou HO, Jeppesen LL, et al. Body temperature in acute
stroke: relation to stroke severity, infarct size, mortality, and
outcome. Lancet 1996;347:422-5.
10. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L,
Re G, et al. Fever in acute stroke worsens prognosis: a
prospective study. Stroke 1995;26:2040-3.
11. Wass CT, Lanier WL, Hofer RE, Scheithauer BW, Andrews
AG. Temperature changes of $ 1° C alter functional neuro-
logic outcome and histopathology in a canine model of
complete cerebral ischemia. Anesthesiology 1995;83:325-35.
12. Warner DS, McFarlane C, Todd MM, Ludwig P, McAllister
AM. Sevoflurane and halothane reduce focal ischemic brain
damage in the rat: possible influence on thermoregulation.
Anesthesiology 1993;79:985-92.
13. Wass CT, Lanier WL. Hypothermia-associated protection
from ischemic brain injury: implications for patient manage-
ment. Int Anesthesiol Clin 1996;34:95-111.
14. Schaff HV, Ciardullo RC, Flaherty JT, Brawley RK, Gott VL.
Regional ischemia distal to a critical coronary stenosis during
prolonged fibrillation—improvement with pulsatile perfu-
sion. J Cardiovasc Surg 1977;56:25-32.
15. Wass CT, Cable DG, Schaff HV, Lanier WL. Anesthetic
technique influences brain temperature during cardiopulmo-
nary bypass in dogs. Ann Thorac Surg 1998;65:454-60.
16. Sadahiro M, Haneda K, Mohri H. Experimental study of
cerebral autoregulation during cardiopulmonary bypass with
or without pulsatile perfusion. J Thorac Cardiovasc Surg
1994;108:446-54.
The Journal of Thoracic and
Cardiovascular Surgery
June 1998
1 3 5 6 Wass et al.
17. Johnston WE, DeWitt DS, Vinten-Johansen J, Stump DA,
Prough DS. Phenylephrine does not reduce cerebral perfu-
sion during canine cardiopulmonary bypass. Anesth Analg
1994;79:14-8.
18. Nussmeier NA. Adverse neurologic events: risks of intracar-
diac versus extracardiac surgery. J Cardiothorac Vasc Anesth
1996;10:31-7.
19. Mills SA. Cerebral injury and cardiac operations. Ann Tho-
rac Surg 1993;56:586-591.
20. Shubert A. Side effects of mild hypothermia. J Neurosurg
Anesthesiol 1995;7:139-47.
21. Hayward JN, Baker MA. Role of cerebral arterial blood in
the regulation of brain temperature in the monkey. Am J
Physiol 1968;215:389-403.
22. Stone JG, Young WL, Smith CR, Solomon RA, Wald A,
Ostapkovich N, et al. Do standard monitoring sites reflect
true brain temperature when profound hypothermia is rap-
idly induced and reversed? Anesthesiology 1995;82:344-51.
23. Minamisawa H, Mellergård P, Smith M-L, Bengtsson F, The-
ander S, Boris-Mo¨ller F, et al. Preservation of brain tempera-
ture during ischemia in rats. Stroke 1990;21:758-64.
24. Cabanac M. Animal selective brain cooling. In: Cabanac M,
editor. Human selective brain cooling. New York: Springer-
Verlag; 1995. p. 1-12.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 6
Wass et al. 1 3 5 7
